BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6860582)

  • 1. Epidermal phospholipase A2 activity is raised in the uninvolved skin of psoriasis.
    Forster S; Ilderton E; Summerly R; Yardley HJ
    Br J Dermatol; 1983 Jul; 109 Suppl 25():30-5. PubMed ID: 6860582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of phospholipase A2 activity in extracts of lesion-free psoriatic epidermis by alkaline phosphatase and a protein phosphatase inhibitor.
    Cartwright PH; Ilchyshyn A; Ilderton E; Yardley HJ
    Br J Dermatol; 1988 Mar; 118(3):333-8. PubMed ID: 2833303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema.
    Forster S; Ilderton E; Norris JF; Summerly R; Yardley HJ
    Br J Dermatol; 1985 Feb; 112(2):135-47. PubMed ID: 3970838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of phospholipase A2 activity is raised in the uninvolved epidermis of psoriasis.
    Forster S; Ilderton E; Summerly R; Yardley HJ
    Br J Dermatol; 1983 Jan; 108(1):103-5. PubMed ID: 6821637
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of phospholipase A activity in psoriatic skin.
    Cantelmi A; Gaiti A; Porcellati G; Ansidei V; Binazzi M
    Farmaco Sci; 1982 Sep; 37(9):612-7. PubMed ID: 6813141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmation of raised phospholipase A2 activity in the uninvolved skin of psoriasis.
    Verhagen A; Bergers M; van Erp PE; Gommans JM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1984 Jun; 110(6):731-2. PubMed ID: 6733043
    [No Abstract]   [Full Text] [Related]  

  • 7. A unique phospholipase A2 in human epidermis: its physiologic function and its level in certain dermatoses.
    Bergers M; Verhagen DR; Jongerius M; van de Kerkhof PC; Mier PD
    J Invest Dermatol; 1988 Jan; 90(1):23-5. PubMed ID: 2447192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I.
    Cartwright PH; Ilderton E; Sowden JM; Yardley HJ
    Br J Dermatol; 1989 Aug; 121(2):155-60. PubMed ID: 2528367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue.
    Andersen S; Sjursen W; Laegreid A; Volden G; Johansen B
    Inflammation; 1994 Feb; 18(1):1-12. PubMed ID: 8206642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raised epidermal phospholipase A2 activity in rheumatoid arthritis.
    Taylor HG; Dawes PT; Ilchyshyn A; Shadforth MF; Ilderton E; Yardley HJ
    Clin Exp Rheumatol; 1991; 9(3):275-7. PubMed ID: 1879087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased phospholipase C-catalyzed hydrolysis of phosphatidylinositol-4,5-bisphosphate and 1,2-sn-diacylglycerol content in psoriatic involved compared to uninvolved and normal epidermis.
    Fisher GJ; Talwar HS; Baldassare JJ; Henderson PA; Voorhees JJ
    J Invest Dermatol; 1990 Oct; 95(4):428-35. PubMed ID: 2170539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial characterization of phospholipase C activity in normal, psoriatic uninvolved, and lesional epidermis.
    Bartel RL; Marcelo CL; Voorhees JJ
    J Invest Dermatol; 1987 Apr; 88(4):447-51. PubMed ID: 3559272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium and calcium-ionophore on the outgrowing epidermis--possible activation of epidermal phospholipase A2.
    Aoyagi T; Umeda K; Kato N; Adachi R; Fukaya T; Nemoto O; Kobayashi H; Miura Y
    J Dermatol; 1983 Aug; 10(4):313-9. PubMed ID: 6421914
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and characterisation of phospholipase A2 from human epidermis.
    Finnen MJ; Lovell CR
    Biochem Soc Trans; 1991 Apr; 19(2):91S. PubMed ID: 1889683
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucocorticoid-induced modulation of the beta-adrenergic adenylate cyclase response of epidermis: its relation to epidermal phospholipase A2 activity.
    Iizuka H; Kajita S; Mizumoto T; Kawaguchi H
    J Invest Dermatol; 1986 Nov; 87(5):577-81. PubMed ID: 3021859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation-dependent regulation of secreted phospholipases A2 in murine epidermis.
    Gurrieri S; Fürstenberger G; Schadow A; Haas U; Singer AG; Ghomashchi F; Pfeilschifter J; Lambeau G; Gelb MH; Kaszkin M
    J Invest Dermatol; 2003 Jul; 121(1):156-64. PubMed ID: 12839576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application study of N-hexadecane on pig skin.
    Kato N; Halprin KM; Ohkawara A; Baker L; Taylor JR
    Hokkaido Igaku Zasshi; 1988 Jan; 63(1):97-102. PubMed ID: 2834282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of a gene for a novel epithelium-specific cytosolic phospholipase A2, cPLA2delta, induced in psoriatic skin.
    Chiba H; Michibata H; Wakimoto K; Seishima M; Kawasaki S; Okubo K; Mitsui H; Torii H; Imai Y
    J Biol Chem; 2004 Mar; 279(13):12890-7. PubMed ID: 14709560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action.
    Norris JF; Ilderton E; Yardley HJ; Summerly R; Forster S
    Br J Dermatol; 1984 Jul; 111 Suppl 27():195-203. PubMed ID: 6743552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phospholipases A of epidermis.
    Freinkel RK; Traczyk TN
    J Invest Dermatol; 1980 Mar; 74(3):169-73. PubMed ID: 7359009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.